Opportunity Information: Apply for RFA CA 18 017
The NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites grant opportunity (Funding Opportunity Number RFA-CA-18-017) is a National Cancer Institute (NCI) cooperative agreement (UG1) that supports institutions and organizations that can function as community-based research sites focused on enrolling, or "accruing," patients from minority and underserved populations into NCI-approved clinical research. The core purpose is to strengthen access to cancer clinical trials and related human subjects research in real-world community settings, especially where patients have historically been underrepresented in research due to geography, socioeconomic barriers, race and ethnicity, age, or other factors tied to health disparities. Because it is a UG1 cooperative agreement, recipients are expected to work closely with NCI and the broader NCORP infrastructure, with NCI having substantial scientific and programmatic involvement compared to a typical grant.
NCORP itself is described as a national community-based research network designed to bring cancer research beyond large academic centers and into the places where many patients actually receive care. Under this program, participating sites take part in designing and conducting clinical trials and other human subjects studies across multiple areas: cancer control, prevention, screening, and care delivery research, along with quality-of-life studies that can be embedded within treatment trials. A major emphasis is ensuring that research questions and study operations reflect the needs of diverse groups, including adolescents and young adults (AYAs), older adults, racial and ethnic minorities, sexual and gender minorities, and rural residents. The opportunity also aligns with the goal of improving participation from these groups by building research capacity and removing practical barriers to enrollment and retention.
A key operational role for Minority/Underserved Community Sites is enrollment into studies that are designed by NCORP Research Bases (one of the three major NCORP components). These sites serve as the community-facing arm of the network, connecting local patient populations to the portfolio of NCI-approved studies in cancer control, prevention, and care delivery. In addition, the FOA highlights that sites will also enhance patient and provider access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN). In practical terms, this means sites are expected to be able to open and run NCTN trials where appropriate, helping patients access advanced therapeutic and imaging studies without needing to travel to major research centers.
The opportunity explicitly positions cancer disparities research as a built-in part of the NCORP community network. Minority/Underserved Community Sites are therefore not only enrolling participants, but also contributing to a broader national effort to understand and reduce disparities in cancer outcomes and care. This includes supporting studies that test interventions or approaches to improve screening uptake, prevention behaviors, symptom management, treatment adherence, care coordination, and other care delivery factors that often drive unequal outcomes. The expectation is that these sites bring local knowledge of community needs and barriers while operating within standardized, high-quality clinical research processes.
Eligibility is broad and includes many types of domestic entities that can support community oncology research operations. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (excluding higher education institutions in those specific categories); for-profit organizations (other than small businesses); small businesses; and other entities as clarified in the full FOA. This range reflects the reality that community cancer care and research infrastructure can sit within hospitals, health systems, academic-community partnerships, tribal health organizations, and other community-based entities.
Administratively, the opportunity is offered by the U.S. Department of Health and Human Services through the National Institutes of Health, with NCI as the sponsoring institute. The FOA was created June 13, 2018, with an original closing date of August 31, 2018, and it anticipated making around 14 awards. The published award ceiling is listed as 0, which typically signals that the maximum was not specified in that field and that applicants should rely on the FOA details for budgeting expectations and constraints. The CFDA numbers associated with the program are 93.393, 93.394, 93.395, and 93.399, reflecting the NCI program areas that commonly align with cancer research, cancer control, and clinical trials activities.
Overall, this funding opportunity is aimed at building and sustaining a set of community sites that can reliably conduct NCI-approved research and enroll participants from minority and underserved populations into both cancer control/care delivery studies and selected NCTN treatment and imaging trials. The larger objective is to make cancer research more representative, increase access to cutting-edge trials in community settings, and embed disparities-focused research into the everyday clinical environments where underserved patients receive care.Apply for RFA CA 18 017
- The Department of Health and Human Services, National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (UG1 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393, 93.394, 93.395, 93.399.
- This funding opportunity was created on Jun 13, 2018.
- Applicants must submit their applications by Aug 31, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 14 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: CSELS Partnership: Strengthening Public Health Laboratories
Previous opportunity: Cooperative Ecosystem Studies Unit, Gulf Coast CESU
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 18 017
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 18 017) also looked into and applied for these:
| Funding Opportunity |
|---|
| NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required) Apply for RFA CA 18 015 Funding Number: RFA CA 18 015 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Required) Apply for RFA CA 19 017 Funding Number: RFA CA 19 017 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional) Apply for PAS 18 915 Funding Number: PAS 18 915 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54 Clinical Trial Not Allowed) Apply for RFA CA 19 016 Funding Number: RFA CA 19 016 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $1,600,000 |
| Administrative Supplements to Cancer Center Support Grants to Strengthen the Research, Training, and Outreach Capacity of the Geographic Management of Cancer Health Disparities Program (Admin Suppl - Clinical Trial Not Allowed) Apply for PA 18 934 Funding Number: PA 18 934 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Optional) Apply for RFA DA 19 008 Funding Number: RFA DA 19 008 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) Apply for PAR 19 032 Funding Number: PAR 19 032 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl Clinical Trial Not Allowed) Apply for PA 19 035 Funding Number: PA 19 035 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $125,000 |
| Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed) Apply for RFA CA 19 013 Funding Number: RFA CA 19 013 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $900,000 |
| HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Coordination and Translation Center (U2C Clinical Trial Optional) Apply for RFA DA 19 024 Funding Number: RFA DA 19 024 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $2,500,000 |
| HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Methodology and Advanced Analytics Resource Center (U2C Clinical Trial Not Allowed) Apply for RFA DA 19 023 Funding Number: RFA DA 19 023 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $2,500,000 |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) Apply for RFA CA 19 029 Funding Number: RFA CA 19 029 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) Apply for RFA CA 19 030 Funding Number: RFA CA 19 030 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Apply for RFA CA 19 022 Funding Number: RFA CA 19 022 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Apply for RFA CA 19 021 Funding Number: RFA CA 19 021 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Apply for RFA CA 19 020 Funding Number: RFA CA 19 020 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Apply for RFA CA 19 019 Funding Number: RFA CA 19 019 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Apply for RFA CA 19 027 Funding Number: RFA CA 19 027 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Apply for RFA CA 19 025 Funding Number: RFA CA 19 025 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Apply for RFA CA 19 026 Funding Number: RFA CA 19 026 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 18 017", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.